Literature DB >> 2018166

Risk factors for needle sharing among methadone-treated patients.

D Metzger1, G Woody, D De Philippis, A T McLellan, C P O'Brien, J J Platt.   

Abstract

OBJECTIVE: This paper examines the sociodemographic and psychiatric characteristics of patients taking methadone who continue to share needles.
METHOD: Three hundred twenty-three patients were recruited from four methadone programs. Data were collected by using questionnaires and interviews. Psychiatric symptoms were measured with the SCL-90, the Beck Depression Inventory, and the Addiction Severity Index.
RESULTS: Twenty percent of these subjects reported sharing needles within the previous 6 months. Those who shared reported greater difficulty in acquiring new needles, more legal difficulties, more severe drug problems, and higher levels of psychiatric symptoms.
CONCLUSIONS: These data suggest that patients who continue to share needles are a more disturbed subgroup of the methadone maintenance population. Efforts designed to reduce needle sharing may need to be more sharply focused on patients who are at greatest risk of infection, and these patients may require more intensive psychiatric services.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2018166     DOI: 10.1176/ajp.148.5.636

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  17 in total

1.  Ignoring 'downstream infection' in the evaluation of harm reduction interventions for injection drug users.

Authors:  H A Pollack
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

Review 2.  Addressing the "risk environment" for injection drug users: the mysterious case of the missing cop.

Authors:  Scott Burris; Kim M Blankenship; Martin Donoghoe; Susan Sherman; Jon S Vernick; Patricia Case; Zita Lazzarini; Stephen Koester
Journal:  Milbank Q       Date:  2004       Impact factor: 4.911

3.  Associations Between Body Weight Status and Substance Use Among African American Women in Baltimore, Maryland: The CHAT Study.

Authors:  Ji Li; Cui Yang; Melissa Davey-Rothwell; Carl Latkin
Journal:  Subst Use Misuse       Date:  2016-04-06       Impact factor: 2.164

4.  Enduring Consequences From the War on Drugs: How Policing Practices Impact HIV Risk Among People Who Inject Drugs in Baltimore City.

Authors:  Natalie Flath; Karin Tobin; Kelly King; Alexandra Lee; Carl Latkin
Journal:  Subst Use Misuse       Date:  2017-03-20       Impact factor: 2.164

5.  The epidemiology of benzodiazepine misuse: A systematic review.

Authors:  Victoria R Votaw; Rachel Geyer; Maya M Rieselbach; R Kathryn McHugh
Journal:  Drug Alcohol Depend       Date:  2019-05-07       Impact factor: 4.492

6.  Co-abuse of opiates and benzodiazepines.

Authors:  S Rooney; G Kelly; L Bamford; D Sloan; J J O'Connor
Journal:  Ir J Med Sci       Date:  1999 Jan-Mar       Impact factor: 1.568

7.  HIV vaccine trials: will intravenous drug users enroll?

Authors:  K Meyers; D S Metzger; H Navaline; G E Woody; A T McLellan
Journal:  Am J Public Health       Date:  1994-05       Impact factor: 9.308

Review 8.  Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond.

Authors:  Stephanie C Licata; James K Rowlett
Journal:  Pharmacol Biochem Behav       Date:  2008-01-12       Impact factor: 3.533

9.  Psychiatric distress, risk behavior, and treatment enrollment among syringe exchange participants.

Authors:  Michael Kidorf; Van L King; Jessica Peirce; Christopher Burke; Ken Kolodner; Robert K Brooner
Journal:  Addict Behav       Date:  2010-01-04       Impact factor: 3.913

10.  Comparison of prescriber evaluations and patient-directed self-reports in office-based practice for buprenorphine treatment of opiate-dependent individuals in France, 2002.

Authors:  Estelle Lavie; Mélina Fatséas; Jean-Pierre Daulouède; Cécile Denis; Jacques Dubernet; Laurent Cattan; Marc Auriacombe
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.